and TAF II 110 S-466 , were sequenced and shown to have mutations at the 5Ј end of exons (6) and (7), respectively. In (g), one TAF II60 allele, TAFII60 , was sequenced and shown to have a mutation in exon (1).
transforms nonneuronal cone cells into R7 photorecepthe first class of cDNAs predicts a novel protein of 558 amino acids (Zn72D) that contains three zinc finger motor cells (Fortini et al., 1992) . These extra R7 cells disrupt tifs. The second class of cDNAs encodes TAF II 110, which the normal packing of cells in ommatidia, resulting in had been previously sequenced and cytologically an external roughening of the eye (for example, see mapped to 72D4-5 (Hoey et al., 1993) . Sequence analy- Figure 1b ). To identify components of the Ras1 signaling sis revealed that while the Zn72D ORF is unaltered in pathway during R7 cell development, an unbiased gethe remaining five SR3-3 alleles, at least two of the alleles netic screen was conducted in which mutations that contain lesions in the TAFII110 ORF ( Figure 1f ). dominantly reduce (suppress) or increase (enhance) the The EMS-induced allele SR3-3 S-466 contains a C-to-T severity of the sev-Ras1 V12 rough eye phenotype were transition in the first position of codon 795, creating a isolated (Karim et al., 1996) . Genetic interaction studies stop codon that C-terminally truncates the normally 921 suggest that five suppressor groups, SR3-3, SR3-4B, aa protein. The X-ray-induced allele SR3-3 XS-793 contains SR3-5, , function as positive regulators a 10 bp deletion that creates a frameshift at amino acid of sev transcription (Karim et al., 1996) . Suppression of 483. These lesions were confirmed by immunoblots of the rough eye phenotype by SR3-3 or SR3-4B alleles is nuclear extracts prepared from SR3-3 S-466 or SR3-3 illustrated in Figure 1 . heterozygous embryos that reveal truncated TAF II 110 The ability of SR3-3 to suppress sev-Ras1 V12 was proteins of the expected size, approximately 90 kDa and mapped to the left arm of the third chromosome, to 50 kDa, respectively (Figures 2g and 2h ). These data meiotic map position 3-47Ϯ5. The lethality associated confirm that SR3-3 corresponds to the TAF II 110 gene; with the SR3-3 alleles was uncovered by two indepenwe therefore renamed this locus TAF II110. dent chromosomal deletions, Df(3L)th102 and Df(3L)st-
The SR3-4B group contains seven X-ray-induced ale4, but was complemented by two others, Df(3L)brm11 leles. Two have chromosomal inversions that break in and Df(3L)st4, placing the gene within the polytene interthe 76C-F region (and may have associated deletions); val 72D1-10. Df(3L)th102 also suppresses sev-Ras1
V12
, four have small deletions that place the gene in the suggesting that SR3-3 alleles are loss-of-function mutapolytene interval 76B6-C; and one, SR3-4B , has no tions. One of the six SR3-3 alleles, SR3-3 XS-2884 , contains cytologically visible rearrangements (F. S., D. A. W., an X-ray-induced inversion breakpoint at 72D. Genomic G. M. R., and R. T., unpublished data). The TAF II 60 gene DNA spanning the breakpoint was isolated and used to maps within this region at 76B9-10 (Weinzierl et al., screen a Drosophila eye-antennal imaginal disc cDNA 1993). Sequencing of the TAF II60 gene from SR3-4B XS- library (see Experimental Procedures). Two classes of 922 revealed an in-frame insertion of six base pairs (TACcDNAs were identified, both of which define transcrip-TAC) that encodes two tyrosine residues adjacent to tion units that are disrupted in SR3-3 XS-2884 . Conceptual position 207 of the protein (Figure 1g ). In addition, SR3-4B failed to complement the lethality of a TAF II 60 translation of the longest open reading frame (ORF) from
R E T R A C T E D

Ras1
V12 suggested that additional suppressor loci may correspond to other TAFIIs. In fact, two of the remaining three suppressor loci (SR3-5 and SR3-8) that genetically display properties of transcriptional regulators map cytologically to positions of known TAF IIs (Karim et al., 1996) . Studies are underway to establish the identity of these loci.
Mutations antibody, and selected (pellet) or unselected (supernamutant TAFs identified in the genetic screen indeed affect Bicoid-dependent activation of transcription in tant) proteins were probed with a polyclonal ␣-TAF II 110 antibody (Figures 2g and 2h ). Both mutant TAF II 110 provitro. First, we tested the ability of the mutant TAF proteins ( Figure 3a) to interact with the activation domains teins were expressed at levels comparable to the wildtype protein (Figures 2g and 2h (Figure 3c ). These results, taken together with our TAF-TAF binding stud-TAFII110⌬C and TAFII110⌬B are not stable components of TFIID in vivo.
ies, suggest that TAF II 110⌬C and TAF II 60YY should behave as transdominant-negative inhibitors that can squelch Bicoid-dependent activation of transcription.
Mutant TAFs Squelch Bicoid-Dependent Activation of Transcription In Vitro
To test this prediction, we determined the effect of these mutant TAFs on Bicoid-dependent activation in Before addressing the physiological relevance of TAFactivator interactions in vivo, we ascertained that the Drosophila nuclear extracts. The DNA template we used
R E T R A C T E D
contained the enhancer/promoter region of the endogenous Bicoid target gene hb fused to a reporter gene encoding Chloramphenicol-acetyl-transferase. Truncated versions of Bicoid bearing either the Q-rich or A-rich activation domains were used as activators (Sauer et al., 1995b) . Primer extension was used to detect transcription products in reactions supplemented with exogenous affinity-purified wild-type or mutant TAFs. As expected, reactions supplemented with either the Q-rich (Figures 3g-3i ) or A-rich activator (Figures 3j and 3k) directed high levels of transcription. These activated levels of transcription were only slightly reduced in the presence of increasing amounts of wildtype TAFII110 or TAFII60 (Figures 3g and 3j , lanes 2 and 3). By contrast, increasing amounts of TAFII110⌬C or TAFII60YY essentially abolished Bicoid-dependent activation of transcription (Figures 3h and 3k, lanes 2 and 3). As expected, mutant TAF II 110⌬B, which is unable to interact with Bicoid, was also unable to squelch transcriptional activation in vitro ( Figure 3i ). These results suggest that mutant versions of TAF II 110 and TAF II 60 that fail to incorporate into the TFIID complex but retain the ability to interact with Bicoid can inhibit Bicoiddependent activation of transcription by sequestering specific activator proteins in nonproductive complexes. mutant TAFs express normal levels of the activator Bicoid. If so, changes in Bicoid-dependent target gene transcription can be attributed to defects in the coactihunchback (hb; and huckebein vator function of TAFs. To assess the pattern of Bicoid, (hkb; Brö nner et al., 1994) . hb is transcribed in a broad embryos derived from heterozygous mothers containing anterior domain, as well as in a more restricted posterior wild-type and mutant alleles of TAF II 110 or TAF II 60 were domain (Figure 5a ), while hkb is expressed in small restained with a polyclonal Bicoid antibody. Wild-type and gions localized to the anterior and posterior ends of heterozygous mutant embryos expressed Bicoid protein the blastoderm (Figure 5f ). Genetic and molecular data to comparable levels with indistinguishable patterns of suggest that transcription of the anterior hb domain is staining in the anterior regions of the embryo (Figure 4 ). activated by a synergistic interplay between Bicoid and The same result was obtained when bcd mRNA was the transcription factor encoded by hb (Hunchback; measured in these embryos by in situ hybridization (F. S., Simpson-Brose et al., 1994) , whereas transcription of D. A. W., and R. T., unpublished data). Thus, bcd tranthe anterior hkb domain depends largely on Bicoid. The scription and expression is apparently not affected by transcription of the posterior hb domain is activated by the presence of mutant TAF II 60 and TAF II 110. This result Tailless (Margolis et al., 1995) and is at least partially was further supported by inspecting the position of the Bicoid-dependent (H. Jä ckle, personal communication). head fold in early embryos. The head fold forms at stage
In contrast, the transcription of the posterior hkb domain 7, and its position critically depends on Bicoid concenis activated by an unknown transcription factor and is trations (Driever and Nü sslein-Volhard, 1988b). Examinot thought to be dependent on Bicoid (Brö nner et al., nation of TAF II 60 and TAF II 110 mutant embryos revealed 1994). We previously established that in vitro, two of that the location of the head furrow is not altered (F. S., the four transcription factors required for hb and hkb D. A. W., and R. T., unpublished data). These results transcription (i.e., Bicoid and Hunchback) mediate actiprovide evidence that bcd transcription and Bicoid convation via an interaction with TAF II60 and TAFII110 (Sauer centration are not adversely affected by mutations in et al., 1995a). TAF II60 or TAFII110.
To assess the effects of mutant TAFs on activated transcription in vivo, we examined hb and hkb transcription in embryos that contained one wild-type and one TAF II 60YY and TAF II 110⌬C Inhibit Bicoid-Dependent Activation transdominant-negative mutant copy of a TAF. These test embryos contained either two (F. S., D. A. W., and of hb and hkb Transcription In the Drosophila embryo, Bicoid activates the transcrip-R. T., unpublished data) or only a single copy of the target gene ( Figure 5 ). For the sake of simplicity, emtion of several zygotic segmentation genes (SimpsonBrose et al., 1994). For our studies, we chose two genes, bryos containing a single copy of the target transcription R E T R A C T E D Figure 5 . Effect of TAF Mutations on hunchback and huckebein Transcription In Vivo hb (a-e) or hkb (f-j) mRNA was visualized by in situ hybridization in embryos containing a single copy of hb (a-e) or hkb (f-j) and heterozygous for mutant TAFII110 (b and c, g and h), TAF II60 (d and i), or TAFII30␣ (e and j). Orientation of the stadium 4-5 embryos is as described in Figure 4 .
unit (i.e., hb or hkb) but carrying two wild-type copies 5e and 5j). We repeated these experiments with embryos containing deletions of TAF II 60 and TAF II 110 instead of of the TAFs will be referred to as "wild-type" embryos. the transdominant-negative alleles. As might be exIn situ hybridization with hb or hkb DNA probes were pected, hb and hkb transcription were reduced in these employed to detect transcription of the target genes.
embryos, but not to the same extent of inhibition as in the Compared to wild-type embryos, transcription within presence of the transdominant-negative alleles (F. S., the anterior and posterior hb domains was significantly D. A. W., and R. T., unpublished data). One possible reduced in heterozygous embryos expressing the transexplanation is that in the case of the deletions the assay dominant-negative version of TAF II 110 (TAF II 110⌬C; Fig- system detects a dosage affect that is partly compenure 5b). This mutant TAF is unable to incorporate into sated by maternally contributed wild-type TAFs in the TFIID but retains its coactivator domain and therefore early embryo. However, in the presence of the transdomcan bind and squelch the activator. By contrast, a TAF inant-negative TAFs, the level of activation is more semutant that is unable to interact and interfere with Bicoid verely impaired by the ability of these proteins to actively activation in vitro (TAF II110⌬B) had no measurable effect squelch the function of the activator. on hb transcription in the embryo (Figure 5c ). Similar
In embryos containing transdominant-negative TAF II60 results were obtained with hkb; in heterozygous emor TAF II 110 alleles, transcription of the posterior hb dobryos carrying one copy of TAF II110⌬C, the transcription main is strongly reduced (Figures 5b and 5d) . These of the anterior, Bicoid-dependent hkb domain was reresults suggest that like Bicoid, the acidic-class activaduced (Figure 5g ). In contrast, transcription of the postetor Tailless might also require TAF II 110 and TAF II 60 in rior hkb domain was not detectably reduced, indicating order to activate hb transcription in vivo. This hypothesis that activation of transcription is not generally impaired is supported by the observation that at least some in these embryos. Again, TAF II 110⌬B had no significant acidic-rich activators are able to target TAF II 60 in order effect on hkb transcription (Figure 5h ). Similar results to activate transcription in vitro (Verrijzer and Tjian, were obtained with embryos containing two copies of 1996). Further, we noted that the transcription of the the target genes (F. S., D. A. W., G. M. R., and R. T., anterior hb domain is more severely reduced in embryos unpublished data). Next, we tested the effect of mutacontaining TAF II 60YY versus TAF II 110⌬C (Figures 5b, 5d , tions in TAF II60, which can also serve as a target for 5g, and 5i). This result is consistent with the in vitro mediating transcriptional activation by Bicoid based on finding that TAF II 60 directs not only Bicoid but also our previous in vitro studies. As expected, transcription Hunchback activation of transcription. In further support of both hb domains and the anterior hkb domain was of this notion, larvae developed from TAF II60 mutant markedly depressed by the presence of TAFII60YY (Figembryos (c-e) P element-derived TAFs (P-TAF) were detected in embryos derived from mothers containing two copies of the P elements expressing TAF II 110 (c), TAF II 110⌬C (d), or TAF II 110⌬B (e) using monoclonal HA antibody. (f-m) Effect of P-TAFs on hb (f-i) and hkb (j-m) transcription in embryos containing a single copy of these Bicoid target genes. "Wild-type" embryos (f and j), embryos containing two copies of P-element plasmids expressing wild-type TAF II110 (g and k), TAFII110⌬C (h and l), and TAF II110⌬B (i and m) were stained using hb (f-i) or hkb (j-m) cDNA probes. The orientation of the stadium 5 embryos is anterior left, dorsal up. lacking the coactivator domain (i.e., TAFII110⌬B) reIn order to bypass the possibility of TAF mutations affecting transcription of important maternal genes, we quired for interaction with Bicoid, as well as other TAFs that are not targeted by Bicoid in vitro, have no signifigenerated flies that synthesized mutant TAFs in the embryo, but not in maternal cells. We achieved this by cant influence on Bicoid-dependent activation of transcription in vivo. These results confirm a role for TAF II 60 employing the same strategy used by the female fly to express Bicoid exclusively in the oocyte. We conand TAF II 110 in the activation of segmentation gene transcription in the Drosophila embryo.
structed P-element plasmids containing epitope-tagged cDNAs encoding wild-type and mutant TAF II 110 that were attached to a transcription unit comprised of the Maternally Derived Mutant TAFs Targeted to the Embryo Squelch Bicoid-Dependent Activation bcd enhancer/promoter and the bcd 3Ј untranslated region (3ЈUTR) (Driever et al., 1990) . The bcd enhancer/ Although we observed that transcription of the maternal bcd gene is not affected by TAF II 60 and TAF II 110 mutapromoter directs the transcription of mutant TAFs in the maternal nurse cells during oogenesis. The bcd 3ЈUTR tions (Figure 4) , we cannot exclude the possibility that they affect transcription of other maternal genes whose mediates the transport and localization of TAF mRNA into the prospective anterior pole of the oocyte, where products are essential for Bicoid-dependent activation of hb and hkb transcription in the embryo. Such maternal TAF and endogenous bcd mRNA are cotranslated during early embryogenesis. These constructs were inserted effects could contribute to the transcriptional defects observed above, especially since the embryos we used into the fly genome by P element-mediated transformation. Antibody staining using a monoclonal antibody diin the previous experiments were derived from heterozygous mutant mothers. This issue was a concern because rected against the epitope tag of the P element-derived TAFs (P-TAF) revealed that they, like Bicoid (Figure 6b ), it became obvious that TAF mutations have a substantial effect on hb and hkb transcription and that the transform an anterior/posterior concentration gradient in the anterior half in embryos derived from mothers condominant TAFs reduce transcription in heterozygous mutant embryos.
taining two copies of the P element (Figures 6c-6e) . The presence of additional P-TAFII110 did not affect above suggested that both TAFII60 and TAFII110 are likely targets for Bicoid-dependent activation of tranthe transcription of either of the target genes (Figures 6g  and 6k ). In contrast, hb transcription, as well as anterior, scription. However, our in vivo studies thus far provide no evidence for discriminating which activation domains Bicoid-dependent hkb transcription, becomes significantly reduced in the presence of P-TAF II 110⌬C (Figures of Bicoid contact which specific TAFs in order to activate transcription. 6h and 6l), but not of P-TAF II 110⌬B (Figures 6i and 6m) . These results suggest that a reduction in Bicoid-mediTo address this issue, we devised an in vivo assay system comprised of an effector gene and a reporter ated activation of hb and hkb transcription in the presence of mutant TAF II 110 is not due to disruption of Bicoid gene that allows us to directly test the functional relevance of select TAF/activator interactions in the Drolocalization or concentration. These experiments also help rule out maternal effects that may contribute to the sophila embryo. The effector gene was designed to express fusion activators under the control of the basal observed reduction of Bicoid-dependent activation in the embryo. Instead, these findings confirm that activaheat-shock promoter fused to an enhancer recognized by the Drosophila transcription factor, Glass, which dition of transcription by Bicoid requires TAFII110, most likely as a coactivator subunit of TFIID, to mediate tranrects cell type-specific expression in the Bolwig organ, a larval light sensor formed during later stages of emscription of natural target genes in vivo.
bryogenesis (Moses and Rubin, 1991 (Figure 7a ). The reporter construct contained poses that for certain activators, direct contact between five Gal4 DNA binding sites linked to the promoter of an activation domain and a specific TAF subunit of TFIID the Drosophila sevenless gene driving the transcription is at least in part responsible for mediating activation of lacZ (Figure 7a ). of transcription (Verrijzer and Tjian, 1996) . Our previous in vitro experiments and the in vivo studies reported
We confirmed the Bolwig organ-specific expression
presence of the Q-rich activator, suggesting that the strong Q-rich activation domain of Bicoid requires TAF II 110 to mediate activation of transcription in vivo (Figure 8c ). In contrast, the weaker A-rich domain activator remains active even in the presence of TAF II 110⌬C, indicating that transcriptional activation is not generally impaired in these embryos (Figure 8d ). The reciprocal result was obtained in homozygous TAF II 60YY mutant embryos: the Q-rich transcription factor supported activation of the reporter gene (Figure 8g ), while the A-rich activator failed to enhance transcription (Figure 8h ). Thus, in agreement with previously reported in vitro studies (Sauer et al., 1995b) , the two different Bicoid activation domains require distinct TAFs to mediate activation of transcription in the Drosophila embryo. Our in vitro studies also suggested a TAF-mediated mechanism for Bicoid-dependent synergistic activation of transcription (Sauer et al., 1995b) . To test the TAF requirements for synergy in vivo, we used a fusion activator containing both the Q-rich and A-rich Bicoid activation domains. As expected, this bipartite activator directs a high level of reporter-gene transcription in the Bolwig organ of wild-type embryos (Figure 9e ). In contrast, the level of activation was significantly reduced, but not eliminated, in TAFII110 homozygous mutant embryos (Figure 9f) . A similar result was observed for the TAFII60 mutant (Figure 9g ). However, in double-homozygous TAF mutant embryos the QA-rich activator essentially gave undetectable levels of reporter-gene tran- These experiments, by in large, recapitulate the results that were observed in vitro where the fusion activator supports weak activation in the presence of only one of of the four different fusion activators in the transgenic the coactivator targets but greater than additive levels embryos by staining with polyclonal anti-Gal4 antibody of activation when both targets are present. Thus, the (Figures 7b-7e) . In situ hybridization with a lacZ probe simultaneous interactions of two different Bicoid activawas used to detect transcription of the reporter gene.
tion domains with distinct TAFs in the TFIID complex As expected, of the four activators, only the control contributes to the synergistic activation of transcription Gal4DBD failed to activate transcription of the reporter in vivo. Our results provide evidence that TAF-activator gene in the Bolwig organ, although the A-rich activator interactions play a role in both simple and synergistic was somewhat weaker than the others (Figures 7f-7i) .
activation of transcription in the Drosophila embryo. We previously established that in vitro, the Q-rich activation domain of Bicoid targets TAF II 110, while the A-rich activation domain contacts TAFII60 in order to activate Discussion transcription (Sauer et al., 1995b) . Here, we have attempted to determine the importance of specific activa-TFIID is required to reconstitute activator-dependent transcription by RNA polymerase II for many promoters tor coactivator interactions in vivo by assaying transcription in embryos homozygous for mutant TAFII60 or in vitro (Dynlacht et al., 1991) . Holo-TFIID isolated from eukaryotic cells is a multiprotein complex comprised of TAFII110. In order to minimize the effects of maternal wild-type TAFs present in the embryo, we used the TATA-binding protein decorated with a host of TAF subunits ( Verrijzer and Tjian, 1996; Roeder, 1996) . It has transdominant-negative TAF alleles, TAF II 110⌬C and TAF II 60YY.
been proposed that eukaryotic organisms have evolved various classes of gene-specific activators that contact In embryos homozygous for mutant TAF II 110⌬C, both fusion activators were expressed to comparable levels one or more TAFs in the TFIID complex in order to mediate transcription of their target genes. Our study extends in the Bolwig organ (Figures 8a and 8b) . However, reporter-gene transcription could not be detected in the the coactivator hypothesis and provides evidence that (i) Quantitative measurements of reporter gene expression. Total cell extracts were prepared from wild-type or homozygous mutant embryos for TAF II 60, TAF II 110, or both. The levels of ␤-galactosidase present in 1 g of embryo extract were measured using a sandwich ELISA assay system. The extracts were standardized based on their relative fusion activator concentrations detected using an ELISA assay. Each bar represents the mean of at least 10 different experiments using 5 distinct extracts. Standard deviations are indicated by bars.
TAFs are also required for activation of transcription in suggest that Bicoid uses the same targets within TFIID to activate the transcription of distinct genes, i.e., hb vivo. Two highly conserved subunits of TFIID, TAF II 60 and TAFII110, are required for Bicoid-dependent tranand hkb. This conclusion is further supported by the observation that Bicoid-dependent activation of two scriptional activation of cognate target genes in the Drosophila embryo. We have shown that two distinct activaother target genes, buttonhead and tailless (Jä ckle and Sauer, 1993) , is also reduced in TAFII60 and TAFII110 tion domains (glutamine-rich and alanine-rich) present in eukaryotic activators require TAFII110 and TAFII60, mutant embryos (F. S., D. A. W., and R. T., unpublished data). However, we cannot exclude the possibility that respectively, in order to mediate transcription. the activation of some Bicoid target genes involves contact between the activator and other TAFs, or between The Role of TAFs in Mediating Activation as yet unidentified coactivators and additional compoof Segmentation Gene Transcription nents of the preinitiation complex. Bicoid is required for the activation of at least ten different zygotic segmentation genes (Hoch and Jä ckle, 1993) . Here, we report that Bicoid utilizes TAF II 60 and Differences between Drosophila and Yeast?
The general transcriptional machinery and the preinitia-TAF II 110 as coactivators to regulate the transcription of two of its target genes, hunchback (hb) and huckebein tion complex are comprised of at least fifty different polypeptides, each of which may be a potential target (hkb). Our results indicate that mutations in TAFII60 and TAFII110 affect the levels of hb transcription in the early for gene-specific activators to regulate transcription initiation (Tjian and Maniatis, 1994; Verrijzer and Tjian, embryo. In addition, these TAF mutations impede the anterior, Bicoid-dependent transcription of hkb, while 1996; Roeder, 1996) . Given the functional similarities between the eukaryotic basal-transcriptional machinery having little or no effect on posterior, Bicoid-independent transcription. It remains possible that other TAFs and sigma factors in prokaryotes it should not be surprising to find that activators may target multiple compoand/or coactivators are required for transcription of hkb in the posterior region of the embryo. These findings nents of the preinitiation complex. For example, in addition to TAFs, activators have been shown to interact in provide strong support for a mechanism in which individual TAFs may be required for the transcriptional activitro with several other components of the preinitiation complex including TBP, TFIIA, and TFIIB (Roeder, 1996) . vation of specific subsets of genes. Our results also
In many cases, the functional relevance of specific actientirely excluded, there is at present no evidence to support this intriguing but speculative scenario. vator interactions with components of the preinitiation complex have not been decisively established. By conIt is also possible, however, that there are significant differences between the function of TAFs in yeast and in trast, the role of TAFs and TFIID in mediating transcriptional activation has been amply documented by a plethmetazoans. For example, it has been generally observed that yeast do not contain a large variety of different ora of in vitro reconstituted transcription reactions (Verrijzer and Tjian, 1996) . However, the majority of these activator classes. Instead, most, if not all, activators that have been characterized from yeast fall into the acidic experiments have been carried out in vitro with isolated polypeptides or highly purified transcription reactions class (Ptashne, 1988) . By contrast, the expanding collection of activators that have been characterized from and leave open the possibility that activities and transactions detected in cell-free systems may not reflect the Drosophila and mammals includes a large variety of distinct classes, such as glutamine-rich, alanine-rich, in vivo situation.
Indeed, recent experiments performed in yeast have isoleucine-rich, proline-rich, and acidic (Tjian and Maniatis, 1994) . More importantly, with the exception of been interpreted to indicate that TAFs are not generally required for transcriptional activation (Moqtaderi et al., the acidic class, many of these metazoan activators failed to function when introduced into yeast, sug-1996; Walker et al., 1996) . Thus, it was possible that experiments establishing the role of TAFs in vitro did gesting that the transcriptional machinery in flies and man may have evolved additional essential components not accurately reflect their function in vivo. However, it is also possible that apparent differences observed to accommodate the increased complexity of gene expression in multicellular organisms. between the role of TAFs in yeast and Drosophila reflect inherent limitations in the experimental strategy that was Perhaps a more limited subset of genes requires TAFs for transcription in yeast, whereas in organisms such as adopted. First, there was no evidence in vitro that the activators chosen for the studies in yeast are able to Drosophila and man, the complexity of developmental, tissue-specific, and stimulus-response cascades of bind specific TAFs or require TAFs for mediating transcriptional activation. Thus, in our view, it is probable gene expression demand a more elaborate transcriptional machinery that is highly dependent on TAFs as that the correct TAF-activator pairs have not been tested. Therefore, eliminating a specific TAF or even a coactivators. Indeed, integral subunits of TFIID, such as Drosophila TAFII110 and human TAFII130, have not been set of TAFs in yeast is not expected to have an effect on transcription of randomly selected genes. Given the found in yeast (Reese et al., 1994; Poon et al., 1995) . These findings may also help to explain why glutaminefact that all experiments, both in vitro and in vivo carried out to date, indicate that TAFs function in a gene-sperich activators failed to function in yeast. Moreover, the recent discovery of a cell-type specific TAF related to cific manner, choosing the appropriate activator-TAF pair becomes critical to analyzing the potential coactiva-TAF II 130 in humans implies even greater degrees of combinational specificity in the coactivator components tor function of these TFIID subunits. Thus, it should be possible to identify specific yeast genes and activators of the preinitiation complex (Dikstein et al., 1996) . that are dependent on TAFs for transcription.
The in vivo studies reported here reveal that in Dro-A Genetic System for Identifying sophila, mutation of even a single TAF is sufficient to Components of the RNA Pol II down-regulate transcription of specific genes during deTranscriptional Machinery velopment. By contrast, reduction or elimination of indiMutations in TAF II60, TAFII110, and possibly other tranvidual TAFs in yeast had no significant effect on transcription factors were isolated as positive regulators scription of several test genes. Despite the obvious of sev transcription because the rough eye phenotype differences between Drosophila and yeast, it is interestcaused by Ras1 V12 is dose-sensitive (Karim et al., 1996) . ing that mutations in TAFs are lethal in both organisms A small change in the level of Ras1 V12 expression is Reese et al., 1994; Poon et al., reflected by a visible change in the external morphology 1995). Moreover, in both yeast and mammalian cells, of the adult eye. It is interesting to note that although certain TAF mutant alleles lead to specific cell-cycle the sev-Ras1 V12 screen was highly sensitive and unbiarrest phenotypes (Wang and Tjian, 1994; ased, and a relatively large number of flies was scored 1996). For example, a mutation in human TAF II250 was ‫,)000,058ف(‬ not all of the known TAF II s could be mutated shown to affect the transcriptional activity of specific to a detectable phenotype. One possibility is that only a genes critical to cell-cycle progression, such as cyclin subset of TAF II s is required to activate sev transcription, A, but not other genes (c-Fos) or global transcription supporting the proposal that TAF IIs do not play a general rates (Wang and Tjian, 1994) . Thus, the most parsimonirole in transcriptional activation (Tjian and Maniatis, ous interpretation would be to conclude that some TAFs 1994). are required to mediate transcriptional activation of select cell-cycle genes. Perhaps transcription of essential Phenotypes of TAF Mutants cell-cycle regulatory genes, such as the cyclins, are govMaternal expression of TAF II 60 and TAF II 110 appears to erned by a subset of transcriptional activators that rebe required for oogenesis, as well as for cell proliferation quire TAFs in both mammals and yeast. However, it has and/or survival, since homozygous germline clones of also been proposed that in yeast, temperature sensitive mutant TAF alleles generated using the ovoD mutation mutations in TAF subunits do not affect transcription in the FLP-FDS system failed to produce eggs, and since but instead directly regulate the cell cycle (Apone et al., 1996) . Although a cell-cycle function of TAFs cannot be mitotic clones of mutant TAF alleles generated in the eye recently described (Sauer et al., 1995a; 1995b) . For protein binding assays, 50 ng of GST or GST-Bicoid fusion proteins were immobiExperimental Procedures lized on glutathione beads incubated with labeled TAFs. Protein binding reactions contained 50 ng of Flag-epitope-tagged TAFII Plasmids or GST-proteins immobilized on Flag-M2 antibody resin (Eastman Baculovirus plasmids expressing mutant TAF IIs were generated by Kodak) or glutathione beads were incubated with 35 S-methionineinserting a 1.7 kb or 1.2 kb NdeI-BamHI fragment encoding TAFII labeled proteins generated using the TNT coupled in vitro transcrip-110⌬C and TAFII110⌬B, respectively, or a 1.8 kb NdeI-BamHI fragtion/translation system (Promega). Protein complexes were proment encoding TAF II60YY into the corresponding restriction sites of cessed and bound proteins detected as previously described (Sauer pSLFlag (Sauer et al., 1995b) . Plasmids expressing GST-A, GST-Q, et al., 1995b) . or GST-QA, or B-A, B-Q, and the reporter plasmid phbCAT-298, were described in Sauer et al. (1995b) . In vitro transcription plasmids Purification of TFIID from Embryos for TAF II 110, TAF II 60, TAF II 30␣, and TFIIA-L have been described Drosophila nuclear extracts were prepared as described by Biggin (Verrijzer and Tjian, 1996; Yokomori et al., 1993) . Plasmids for in and Tjian (1988) and applied onto a heparin column, and the 0.4 M vitro transcription of mutant TAFs were generated by cloning cDNAs HEMG eluate was used for the immunopurification of TFIID. Antifor TAF II110⌬C or TAFII110⌬B as NdeI-XbaI, or for TAFII60YY as body resin containing monoclonal TAF II 250 antibody (2B2). Resin NdeI-BamHI fragment into pTbSTOP.
was incubated with 500 mg 0.4 eluate for 12 hr at 4ЊC, washed with To express TAFs under control of the bcd transcription unit, a 1 M HEMG-NP, and supe and resin were resolved by SDS-PAGE. 125 bp BglII-NdeI fragment containing the ␤-globin leader and the Proteins were transferred onto nitrocellulose and TAF II110, and dehemaglutinin epitope tag was inserted into pAR110 to generate rivatives were detected using a polyclonal TAF II110 antibody pGHA110. A 850 bp EcoRV-XbaI fragment containing the bcd 3ЈUTR
(1:10000 dilution). was cloned into pBluescriptBglII (F. S., unpublished data), containing a BglII at the position of the XhoI site, to generate pB3ЈUTR. To generate TAF II110 /bcd 3ЈUTR a 2.1 kb BglII-XbaI (blunt end ), Drosophila Strains and Transgenic Lines Drosophila stocks were raised under standard conditions. The hb a 1.75 BglII-BamHI (blunt end), 1.2 kb BglII-XmnI fragments derived from pGHA110 were cloned into the BglII-EcoRV restriction sites stock Df(3R)p-XT103 has been described by Lehmann and Nü ssleinVolhard (1987) ; the hkb stock hkbXM9, by Brö nner et al. (1995) . The of pB3ЈUTR to generate pGHA-110UTR, pGHA-110DCUTR, or pGHAϪ110DBUTR, respectively. Fusion genes were inserted as receptor strain for P-element plasmids w 1118 was injected with DNA at a concentration of 1.0 mg/ml with 100 mg/ml helper plasmid BglII-XbaI into pC-bcd, a pCaSpeR derivative containing a 2.2 kb BamHI-PstI bcd enhancer/promoter fragment (Driever et al., 1990 ) (Karess and Rubin, 1984) . For each construct, four independent lines were established. The chromosomal location of the P elements to generate pC-bcd-110UTR, pC-bcd-110DCUTR, or pC-bcd-110DBUTR. P-element plasmids expressing Gal4/Bicoid fusion prowas determined by crossing the transgenic lines with balanced strains. teins were constructed by inserting 166 bp NdeI-HinPI, 132 bp AccII- 
